Lawrence Cullen is a Deputy Director in the Patents Examination Division of the UK Intellectual Property Office (UK-IPO). He leads the team responsible for patent applications in the biotechnology field and he and his team also handle the examination of applications for Supplementary Protection Certificates (SPCs). He acts as a hearing officer at the IPO and has been involved in a number of patent and SPC cases before the UK courts and the Court of Justice of the European Union (CJEU).
This presentation will briefly consider what is the basis for patents on genetic sequences and why are such patents important; What cannot be patented and what can!; Relevance of diagnostic kits versus medical use; the interest in Diagnostic Markers; inventions based on bioinformatics, data mining, and homology searches; a brief summary of the situation in some other countries; guidelines on examining parent applications for medical invention and for Biotechnological inventions.